← Back to Search

Monoclonal Antibodies

JS004 200 mg in combination with toripalimab 240 mg was administered every 3 weeks as planned for Lung Cancer

Phase 1 & 2
Recruiting
Research Sponsored by Shanghai Junshi Bioscience Co., Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This is an open-label phase I/II study to evaluate the safety, tolerability, pharmacokinetics and initial efficacy of JS004 injection combined with toripalimab in patients with advanced lung cancer who have failed standard therapy.

Eligible Conditions
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The incidence of adverse events (AE) and serious adverse events (SAE) were assessed
Secondary outcome measures
AUC0-inf
AUC0-t
CL/F
+10 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: JS004 200 mg in combination with toripalimab 240 mg was administered every 3 weeks as plannedExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Shanghai Junshi Bioscience Co., Ltd.Lead Sponsor
112 Previous Clinical Trials
27,177 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of JS004 Combined With Toripalimab for Advanced Lung Cancer
2021. "Study of JS004 Combined With Toripalimab for Advanced Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05000684.
~18 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top